Cline Darren S

Director at IMPERIAL INDUSTRIES INC · on record since Jun 20, 2023
Chief Commercial Officer at Xenon Pharmaceuticals Inc. · on record since Jun 24, 2025
Director at PLIANT THERAPEUTICS, INC. · on record since Jun 12, 2026
EVP, Commercial at SEATTLE GENETICS INC /WA · on record since Feb 7, 2018
Director at STEMLINE THERAPEUTICS INC · on record since Apr 26, 2018
U.S. Chief Commercial Officer at GW PHARMACEUTICALS PLC · on record since May 30, 2019
Director at Pyxis Oncology, Inc. · on record since Oct 12, 2021

Insider trading activity of Cline Darren S

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
PLIANT THERAPEUTICS, INC.	Jun 12, 2026	AwardD	70,000	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Mar 25, 2026	AwardD	45,867	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jan 9, 2026	AwardD	20,000	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jan 9, 2026	AwardD	40,000	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 24, 2025	AwardD	185,800	0.00 USD	$0	SEC
PLIANT THERAPEUTICS, INC.	Jun 9, 2025	AwardD	30,000	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Apr 2, 2025	AwardD	36,979	0.98 USD	$36.2K	SEC
PLIANT THERAPEUTICS, INC.	Jun 17, 2024	AwardD	26,764	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Mar 28, 2024	Award	35,219	0.00 USD	$0	SEC
IMPERIAL INDUSTRIES INC	Jun 20, 2023	AwardD	13,222	0.00 USD	$0	SEC
PLIANT THERAPEUTICS, INC.	Jun 8, 2023	AwardD	14,000	0.00 USD	$0	SEC
IMPERIAL INDUSTRIES INC	Apr 14, 2023	AwardD	20,013	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Mar 28, 2023	Award	139,355	0.00 USD	$0	SEC
PLIANT THERAPEUTICS, INC.	Mar 8, 2023	AwardD	22,000	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Apr 4, 2022	Award	66,831	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Dec 9, 2021	Buy	10,000	9.39 USD	$93.9K	SEC
Pyxis Oncology, Inc.	Oct 12, 2021	AwardD	42,191	0.00 USD	$0	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-54,192	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-106,320	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-46,896	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-177,180	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	Other	-5,556	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-75,024	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-22,068	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-98,040	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
PLIANT THERAPEUTICS, INC.	Jun 12, 2026	AwardD	70,000	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Mar 25, 2026	AwardD	45,867	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jan 9, 2026	AwardD	20,000	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jan 9, 2026	AwardD	40,000	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 24, 2025	AwardD	185,800	0.00 USD	$0	SEC
PLIANT THERAPEUTICS, INC.	Jun 9, 2025	AwardD	30,000	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Apr 2, 2025	AwardD	36,979	0.98 USD	$36.2K	SEC
PLIANT THERAPEUTICS, INC.	Jun 17, 2024	AwardD	26,764	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Mar 28, 2024	Award	35,219	0.00 USD	$0	SEC
IMPERIAL INDUSTRIES INC	Jun 20, 2023	AwardD	13,222	0.00 USD	$0	SEC
PLIANT THERAPEUTICS, INC.	Jun 8, 2023	AwardD	14,000	0.00 USD	$0	SEC
IMPERIAL INDUSTRIES INC	Apr 14, 2023	AwardD	20,013	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Mar 28, 2023	Award	139,355	0.00 USD	$0	SEC
PLIANT THERAPEUTICS, INC.	Mar 8, 2023	AwardD	22,000	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Apr 4, 2022	Award	66,831	0.00 USD	$0	SEC
Pyxis Oncology, Inc.	Dec 9, 2021	Buy	10,000	9.39 USD	$93.9K	SEC
Pyxis Oncology, Inc.	Oct 12, 2021	AwardD	42,191	0.00 USD	$0	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-54,192	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-106,320	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-46,896	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-177,180	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	Other	-5,556	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-75,024	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-22,068	—	—	SEC
GW PHARMACEUTICALS PLC	May 7, 2021	OtherD	-98,040	—	—	SEC